Document Detail


Intravenous epoprostenol treatment of patients with connective tissue disease and pulmonary arterial hypertension at a single center.
MedLine Citation:
PMID:  23359006     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
OBJECTIVE: To assess the efficacy of epoprostenol treatment in Japanese patients with pulmonary arterial hypertension (PAH) associated with connective tissue disease (CTD). METHODS: Sixteen patients with PAH-CTD treated with continuous intravenous epoprostenol at a single center between 2000 and 2009 were enrolled. Baseline characteristics, short-term and long-term outcomes, predictors of mortality, and safety profiles were evaluated. For survival analysis, 16 controls were selected who matched the underlying CTD, World Health Organization functional class, and use of PAH drugs, except for epoprostenol. RESULTS: Six patients had systemic lupus erythematosus, five had mixed CTD, four had systemic sclerosis, and one had primary Sjögren's syndrome. The mean pulmonary arterial pressure (mPAP), cardiac index (CI), pulmonary vascular resistance, and functional class were significantly improved during the first 6 months of epoprostenol treatment. Cumulative survival rates at 1, 2, and 3 years in epoprostenol-treated patients were 69, 69, and 55 %, respectively, and were significantly better than those of the controls. Functional class, CI at baseline, and reduction of mPAP at 6 months were identified as predictors of survival. Adverse events, including flushing and catheter-related infection, were frequent, but all patients tolerated the treatment. CONCLUSION: Based on the improvements in both short-term and long-term outcomes among our patient cohort, epoprostenol is an effective treatment for CTD patients with advanced PAH.
Authors:
Yuichiro Shirai; Hidekata Yasuoka; Tsutomu Takeuchi; Toru Satoh; Masataka Kuwana
Related Documents :
24005956 - Once-daily simeprevir (tmc435) with peginterferon/ribavirin for treatment-naïve hepati...
24002386 - Early outcome of endovascular aneurysm repair in challenging aortic neck morphology bas...
23904246 - Does vitamin d improve osteoarthritis of the knee: a randomized controlled pilot trial.
24357956 - Augmentation vs nonaugmentation techniques for open repairs of achilles tendon ruptures...
23886406 - Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total...
1959266 - Unicompartmental prosthesis for gonarthrosis. a nine-year series of 575 knees from a sw...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-29
Journal Detail:
Title:  Modern rheumatology / the Japan Rheumatism Association     Volume:  -     ISSN:  1439-7609     ISO Abbreviation:  Mod Rheumatol     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-29     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100959226     Medline TA:  Mod Rheumatol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Molecular mechanisms of central leptin resistance in obesity.
Next Document:  Young male patient diagnosed with cutaneous polyarteritis nodosa successfully treated with etanercep...